Literature DB >> 18775323

Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination.

Gang Li1, Frederick W Alt, Hwei-Ling Cheng, James W Brush, Peter H Goff, Mike M Murphy, Sonia Franco, Yu Zhang, Shan Zha.   

Abstract

Mutations in XLF/Cernunnos (XLF) cause lymphocytopenia in humans, and various studies suggest an XLF role in classical nonhomologous end joining (C-NHEJ). We now find that XLF-deficient mouse embryonic fibroblasts are ionizing radiation (IR) sensitive and severely impaired for ability to support V(D)J recombination. Yet mature lymphocyte numbers in XLF-deficient mice are only modestly decreased. Moreover, XLF-deficient pro-B lines, while IR-sensitive, perform V(D)J recombination at nearly wild-type levels. Correspondingly, XLF/p53-double-deficient mice are not markedly prone to the pro-B lymphomas that occur in previously characterized C-NHEJ/p53-deficient mice; however, like other C-NHEJ/p53-deficient mice, they still develop medulloblastomas. Despite nearly normal V(D)J recombination in developing B cells, XLF-deficient mature B cells are moderately defective for immunoglobulin heavy-chain class switch recombination. Together, our results implicate XLF as a C-NHEJ factor but also indicate that developing mouse lymphocytes harbor cell-type-specific factors/pathways that compensate for the absence of XLF function during V(D)J recombination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775323      PMCID: PMC2630261          DOI: 10.1016/j.molcel.2008.07.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.

Authors:  Andrea L Bredemeyer; Girdhar G Sharma; Ching-Yu Huang; Beth A Helmink; Laura M Walker; Katrina C Khor; Beth Nuskey; Kathleen E Sullivan; Tej K Pandita; Craig H Bassing; Barry P Sleckman
Journal:  Nature       Date:  2006-06-14       Impact factor: 49.962

2.  XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.

Authors:  Peter Ahnesorg; Philippa Smith; Stephen P Jackson
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

3.  DNA ligase IV suppresses medulloblastoma formation.

Authors:  Youngsoo Lee; Peter J McKinnon
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

4.  Ku80 is required for immunoglobulin isotype switching.

Authors:  R Casellas; A Nussenzweig; R Wuerffel; R Pelanda; A Reichlin; H Suh; X F Qin; E Besmer; A Kenter; K Rajewsky; M C Nussenzweig
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

5.  Nonhomologous end joining and V(D)J recombination require an additional factor.

Authors:  Y Dai; B Kysela; L A Hanakahi; K Manolis; E Riballo; M Stumm; T O Harville; S C West; M A Oettinger; P A Jeggo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  Crystal structure of human XLF: a twist in nonhomologous DNA end-joining.

Authors:  Sara N Andres; Mauro Modesti; Chun J Tsai; Gilbert Chu; Murray S Junop
Journal:  Mol Cell       Date:  2007-12-28       Impact factor: 17.970

7.  Rad54 and DNA Ligase IV cooperate to maintain mammalian chromatid stability.

Authors:  Kevin D Mills; David O Ferguson; Jeroen Essers; Mark Eckersdorff; Roland Kanaar; Frederick W Alt
Journal:  Genes Dev       Date:  2004-06-01       Impact factor: 11.361

8.  A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination.

Authors:  Y Gao; J Chaudhuri; C Zhu; L Davidson; D T Weaver; F W Alt
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

9.  Evolutionary and functional conservation of the DNA non-homologous end-joining protein, XLF/Cernunnos.

Authors:  Pierre Hentges; Peter Ahnesorg; Robert S Pitcher; Chris K Bruce; Boris Kysela; Andrew J Green; Julie Bianchi; Thomas E Wilson; Stephen P Jackson; Aidan J Doherty
Journal:  J Biol Chem       Date:  2006-10-12       Impact factor: 5.157

10.  Single-stranded DNA ligation and XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: influence of terminal DNA sequence.

Authors:  Jiafeng Gu; Haihui Lu; Albert G Tsai; Klaus Schwarz; Michael R Lieber
Journal:  Nucleic Acids Res       Date:  2007-08-23       Impact factor: 16.971

View more
  103 in total

1.  Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells.

Authors:  Tadi Satish Kumar; Vijayalakshmi Kari; Bibha Choudhary; Mridula Nambiar; T S Akila; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

2.  Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1).

Authors:  Cristian Boboila; Valentyn Oksenych; Monica Gostissa; Jing H Wang; Shan Zha; Yu Zhang; Hua Chai; Cheng-Sheng Lee; Mila Jankovic; Liz-Marie Albertorio Saez; Michel C Nussenzweig; Peter J McKinnon; Frederick W Alt; Bjoern Schwer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombination and DNA repair.

Authors:  Valentyn Oksenych; Frederick W Alt; Vipul Kumar; Bjoern Schwer; Duane R Wesemann; Erica Hansen; Harin Patel; Arthur Su; Chunguang Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 4.  The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.

Authors:  Yu Zhang; Monica Gostissa; Dominic G Hildebrand; Michael S Becker; Cristian Boboila; Roberto Chiarle; Susanna Lewis; Frederick W Alt
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

5.  Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency.

Authors:  Wenxia Jiang; Brian J Lee; Chen Li; Richard L Dubois; Monica Gostissa; Frederick W Alt; Shan Zha
Journal:  Blood       Date:  2015-02-26       Impact factor: 22.113

Review 6.  Structural insights into NHEJ: building up an integrated picture of the dynamic DSB repair super complex, one component and interaction at a time.

Authors:  Gareth J Williams; Michal Hammel; Sarvan Kumar Radhakrishnan; Dale Ramsden; Susan P Lees-Miller; John A Tainer
Journal:  DNA Repair (Amst)       Date:  2014-03-20

7.  Mre11: roles in DNA repair beyond homologous recombination.

Authors:  Shan Zha; Cristian Boboila; Frederick W Alt
Journal:  Nat Struct Mol Biol       Date:  2009-08       Impact factor: 15.369

8.  A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.

Authors:  Mirjam van der Burg; Hanna Ijspeert; Nicole S Verkaik; Tuba Turul; Wouter W Wiegant; Keiko Morotomi-Yano; Pierre-Olivier Mari; Ilhan Tezcan; David J Chen; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

9.  A role for XLF in DNA repair and recombination in human somatic cells.

Authors:  Farjana Jahan Fattah; Junghun Kweon; Yongbao Wang; Eu Han Lee; Yinan Kan; Natalie Lichter; Natalie Weisensel; Eric A Hendrickson
Journal:  DNA Repair (Amst)       Date:  2014-01-21

Review 10.  Lymphocyte development: integration of DNA damage response signaling.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.